Share Facebook Twitter Email This phase 1 trial safely escalated dose from 22 Gy to 28 Gy in 1 fraction for cutaneous melanoma mets using FLASH-RT (9MeV electrons, Mobetron, 200 Gy/s) with no dose limiting (acute grade 3+) toxicity. | Kinj, Radiother Oncol 2026 FLASH
